Does the media favor IPAR or PBH?

In the previous week, Prestige Consumer Healthcare had 2 more articles in the media than Interparfums. MarketBeat recorded 3 mentions for Prestige Consumer Healthcare and 1 mentions for Interparfums. Interparfums' average media sentiment score of 1.46 beat Prestige Consumer Healthcare's score of 0.45 indicating that Interparfums is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Interparfums 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Prestige Consumer Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor HLF or PBH?

In the previous week, Herbalife had 2 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 5 mentions for Herbalife and 3 mentions for Prestige Consumer Healthcare. Herbalife's average media sentiment score of 0.79 beat Prestige Consumer Healthcare's score of 0.45 indicating that Herbalife is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Herbalife 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Prestige Consumer Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to PBH or USNA?

In the previous week, USANA Health Sciences had 1 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 4 mentions for USANA Health Sciences and 3 mentions for Prestige Consumer Healthcare. USANA Health Sciences' average media sentiment score of 0.52 beat Prestige Consumer Healthcare's score of 0.45 indicating that USANA Health Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Prestige Consumer Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral USANA Health Sciences 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Prestige Consumer Healthcare (PBH) Competitors

$49.92 -0.68 (-1.34%)

Closing price 03:59 PM Eastern

Extended Trading

$49.92 0.00 (0.00%)

As of 07:42 PM Eastern

Compare

PBH vs. IPAR, HLF, USNA, NATR, and NUS

Should you buy Prestige Consumer Healthcare stock or one of its competitors? MarketBeat compares Prestige Consumer Healthcare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Prestige Consumer Healthcare include Interparfums (IPAR), Herbalife (HLF), USANA Health Sciences (USNA), Nature's Sunshine Products (NATR), and Nu Skin Enterprises (NUS). These companies are all part of the "personal products" industry.

How does Prestige Consumer Healthcare compare to Interparfums?

Interparfums (NASDAQ:IPAR) and Prestige Consumer Healthcare (NYSE:PBH) are both mid-cap personal products companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends.

Interparfums has a beta of 1.13, indicating that its share price is 13% more volatile than the broader market. Comparatively, Prestige Consumer Healthcare has a beta of 0.35, indicating that its share price is 65% less volatile than the broader market.

55.6% of Interparfums shares are held by institutional investors. Comparatively, 100.0% of Prestige Consumer Healthcare shares are held by institutional investors. 43.7% of Interparfums shares are held by company insiders. Comparatively, 1.5% of Prestige Consumer Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Interparfums presently has a consensus target price of $106.00, suggesting a potential downside of 13.98%. Prestige Consumer Healthcare has a consensus target price of $70.75, suggesting a potential upside of 41.72%. Given Prestige Consumer Healthcare's higher probable upside, analysts clearly believe Prestige Consumer Healthcare is more favorable than Interparfums.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Interparfums	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.75
Prestige Consumer Healthcare	2 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

Prestige Consumer Healthcare has a net margin of 17.48% compared to Interparfums' net margin of 11.32%. Interparfums' return on equity of 15.47% beat Prestige Consumer Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Interparfums	11.32%	15.47%	10.82%
Prestige Consumer Healthcare	17.48%	11.54%	6.16%

Prestige Consumer Healthcare has lower revenue, but higher earnings than Interparfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Interparfums	$1.49B	2.65	$168.39M	$5.27	23.38
Prestige Consumer Healthcare	$1.09B	2.17	$190.30M	$3.91	12.77

In the previous week, Prestige Consumer Healthcare had 2 more articles in the media than Interparfums. MarketBeat recorded 3 mentions for Prestige Consumer Healthcare and 1 mentions for Interparfums. Interparfums' average media sentiment score of 1.46 beat Prestige Consumer Healthcare's score of 0.45 indicating that Interparfums is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Interparfums	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Prestige Consumer Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Interparfums beats Prestige Consumer Healthcare on 12 of the 17 factors compared between the two stocks.

How does Prestige Consumer Healthcare compare to Herbalife?

Herbalife (NYSE:HLF) and Prestige Consumer Healthcare (NYSE:PBH) are both personal products companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and media sentiment.

Herbalife currently has a consensus price target of $17.80, suggesting a potential upside of 48.25%. Prestige Consumer Healthcare has a consensus price target of $70.75, suggesting a potential upside of 41.72%. Given Herbalife's stronger consensus rating and higher probable upside, analysts plainly believe Herbalife is more favorable than Prestige Consumer Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Herbalife	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43
Prestige Consumer Healthcare	2 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

Herbalife has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market. Comparatively, Prestige Consumer Healthcare has a beta of 0.35, indicating that its share price is 65% less volatile than the broader market.

Herbalife has higher revenue and earnings than Prestige Consumer Healthcare. Herbalife is trading at a lower price-to-earnings ratio than Prestige Consumer Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Herbalife	$5.04B	0.25	$228.30M	$2.28	5.27
Prestige Consumer Healthcare	$1.09B	2.17	$190.30M	$3.91	12.77

Prestige Consumer Healthcare has a net margin of 17.48% compared to Herbalife's net margin of 4.67%. Prestige Consumer Healthcare's return on equity of 11.54% beat Herbalife's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Herbalife	4.67%	-41.47%	8.24%
Prestige Consumer Healthcare	17.48%	11.54%	6.16%

100.0% of Prestige Consumer Healthcare shares are held by institutional investors. 5.1% of Herbalife shares are held by insiders. Comparatively, 1.5% of Prestige Consumer Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Herbalife had 2 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 5 mentions for Herbalife and 3 mentions for Prestige Consumer Healthcare. Herbalife's average media sentiment score of 0.79 beat Prestige Consumer Healthcare's score of 0.45 indicating that Herbalife is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Herbalife	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Prestige Consumer Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Herbalife beats Prestige Consumer Healthcare on 10 of the 16 factors compared between the two stocks.

How does Prestige Consumer Healthcare compare to USANA Health Sciences?

Prestige Consumer Healthcare (NYSE:PBH) and USANA Health Sciences (NYSE:USNA) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, media sentiment, profitability, dividends, earnings and analyst recommendations.

Prestige Consumer Healthcare has a beta of 0.35, meaning that its share price is 65% less volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.73, meaning that its share price is 27% less volatile than the broader market.

Prestige Consumer Healthcare has higher revenue and earnings than USANA Health Sciences. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prestige Consumer Healthcare	$1.09B	2.17	$190.30M	$3.91	12.77
USANA Health Sciences	$925.26M	0.44	$10.76M	$0.47	46.48

100.0% of Prestige Consumer Healthcare shares are owned by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are owned by institutional investors. 1.5% of Prestige Consumer Healthcare shares are owned by insiders. Comparatively, 0.8% of USANA Health Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Prestige Consumer Healthcare has a net margin of 17.48% compared to USANA Health Sciences' net margin of 0.96%. Prestige Consumer Healthcare's return on equity of 11.54% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prestige Consumer Healthcare	17.48%	11.54%	6.16%
USANA Health Sciences	0.96%	6.21%	4.50%

Prestige Consumer Healthcare currently has a consensus target price of $70.75, suggesting a potential upside of 41.72%. Given Prestige Consumer Healthcare's stronger consensus rating and higher possible upside, equities analysts plainly believe Prestige Consumer Healthcare is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prestige Consumer Healthcare	2 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, USANA Health Sciences had 1 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 4 mentions for USANA Health Sciences and 3 mentions for Prestige Consumer Healthcare. USANA Health Sciences' average media sentiment score of 0.52 beat Prestige Consumer Healthcare's score of 0.45 indicating that USANA Health Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Prestige Consumer Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
USANA Health Sciences	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Prestige Consumer Healthcare beats USANA Health Sciences on 12 of the 16 factors compared between the two stocks.

How does Prestige Consumer Healthcare compare to Nature's Sunshine Products?

Prestige Consumer Healthcare (NYSE:PBH) and Nature's Sunshine Products (NASDAQ:NATR) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, profitability, earnings and analyst recommendations.

In the previous week, Prestige Consumer Healthcare had 2 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 3 mentions for Prestige Consumer Healthcare and 1 mentions for Nature's Sunshine Products. Nature's Sunshine Products' average media sentiment score of 1.89 beat Prestige Consumer Healthcare's score of 0.45 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Prestige Consumer Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nature's Sunshine Products	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

100.0% of Prestige Consumer Healthcare shares are owned by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are owned by institutional investors. 1.5% of Prestige Consumer Healthcare shares are owned by company insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Prestige Consumer Healthcare has a beta of 0.35, meaning that its stock price is 65% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market.

Prestige Consumer Healthcare presently has a consensus price target of $70.75, suggesting a potential upside of 41.72%. Nature's Sunshine Products has a consensus price target of $35.00, suggesting a potential upside of 71.32%. Given Nature's Sunshine Products' stronger consensus rating and higher probable upside, analysts plainly believe Nature's Sunshine Products is more favorable than Prestige Consumer Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prestige Consumer Healthcare	2 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
Nature's Sunshine Products	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00

Prestige Consumer Healthcare has higher revenue and earnings than Nature's Sunshine Products. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prestige Consumer Healthcare	$1.09B	2.17	$190.30M	$3.91	12.77
Nature's Sunshine Products	$480.14M	0.75	$19.52M	$1.10	18.57

Prestige Consumer Healthcare has a net margin of 17.48% compared to Nature's Sunshine Products' net margin of 4.06%. Nature's Sunshine Products' return on equity of 14.67% beat Prestige Consumer Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prestige Consumer Healthcare	17.48%	11.54%	6.16%
Nature's Sunshine Products	4.06%	14.67%	9.27%

Summary

Nature's Sunshine Products beats Prestige Consumer Healthcare on 9 of the 17 factors compared between the two stocks.

How does Prestige Consumer Healthcare compare to Nu Skin Enterprises?

Prestige Consumer Healthcare (NYSE:PBH) and Nu Skin Enterprises (NYSE:NUS) are both personal products companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, earnings, analyst recommendations and dividends.

Prestige Consumer Healthcare has higher earnings, but lower revenue than Nu Skin Enterprises. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Prestige Consumer Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prestige Consumer Healthcare	$1.09B	2.17	$190.30M	$3.91	12.77
Nu Skin Enterprises	$1.49B	0.17	$160.20M	$1.10	4.76

Prestige Consumer Healthcare has a beta of 0.35, meaning that its stock price is 65% less volatile than the broader market. Comparatively, Nu Skin Enterprises has a beta of 0.97, meaning that its stock price is 3% less volatile than the broader market.

Prestige Consumer Healthcare has a net margin of 17.48% compared to Nu Skin Enterprises' net margin of 3.78%. Prestige Consumer Healthcare's return on equity of 11.54% beat Nu Skin Enterprises' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prestige Consumer Healthcare	17.48%	11.54%	6.16%
Nu Skin Enterprises	3.78%	7.47%	4.21%

In the previous week, Prestige Consumer Healthcare had 3 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 3 mentions for Prestige Consumer Healthcare and 0 mentions for Nu Skin Enterprises. Prestige Consumer Healthcare's average media sentiment score of 0.45 beat Nu Skin Enterprises' score of 0.00 indicating that Prestige Consumer Healthcare is being referred to more favorably in the media.

Company	Overall Sentiment
Prestige Consumer Healthcare	Neutral
Nu Skin Enterprises	Neutral

Prestige Consumer Healthcare currently has a consensus target price of $70.75, suggesting a potential upside of 41.72%. Given Prestige Consumer Healthcare's stronger consensus rating and higher probable upside, research analysts clearly believe Prestige Consumer Healthcare is more favorable than Nu Skin Enterprises.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prestige Consumer Healthcare	2 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
Nu Skin Enterprises	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

100.0% of Prestige Consumer Healthcare shares are owned by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are owned by institutional investors. 1.5% of Prestige Consumer Healthcare shares are owned by insiders. Comparatively, 2.8% of Nu Skin Enterprises shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Prestige Consumer Healthcare beats Nu Skin Enterprises on 13 of the 16 factors compared between the two stocks.

Get Prestige Consumer Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PBH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PBH vs. The Competition

Export

Metric	Prestige Consumer Healthcare	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$2.40B	$8.89B	$6.90B	$23.50B
Dividend Yield	N/A	2.45%	2.67%	4.15%
P/E Ratio	12.77	16.06	27.17	30.91
Price / Sales	2.17	6.87	526.21	19.87
Price / Cash	9.72	18.35	51.46	32.65
Price / Book	1.25	3.28	10.69	4.75
Net Income	$190.30M	$228.19M	$3.59B	$1.07B
7 Day Performance	2.04%	-2.43%	-2.17%	-0.01%
1 Month Performance	8.55%	-0.61%	2.08%	1.62%
1 Year Performance	-33.61%	-0.89%	24.68%	16.41%

Prestige Consumer Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PBH Prestige Consumer Healthcare	3.9277 of 5 stars	$49.92 -1.3%	$70.75 +41.7%	-32.6%	$2.40B	$1.09B	12.77	540	Positive News
IPAR Interparfums	2.5345 of 5 stars	$123.24 +1.8%	$106.00 -14.0%	-7.9%	$3.95B	$1.49B	23.39	530	Positive News
HLF Herbalife	4.317 of 5 stars	$13.24 +2.9%	$17.80 +34.4%	+35.8%	$1.37B	$5.04B	5.81	8,500	News Coverage Positive News
USNA USANA Health Sciences	2.3118 of 5 stars	$21.99 +1.0%	N/A	-27.5%	$405.94M	$925.26M	46.79	1,570
NATR Nature's Sunshine Products	3.4664 of 5 stars	$21.81 +0.6%	$35.00 +60.5%	+40.2%	$383.33M	$480.14M	19.82	850	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:PBH) was last updated on 7/17/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Prestige Consumer Healthcare (PBH) Competitors

PBH vs. IPAR, HLF, USNA, NATR, and NUS

How does Prestige Consumer Healthcare compare to Interparfums?

Summary

How does Prestige Consumer Healthcare compare to Herbalife?

Summary

How does Prestige Consumer Healthcare compare to USANA Health Sciences?

Summary

How does Prestige Consumer Healthcare compare to Nature's Sunshine Products?

Summary

How does Prestige Consumer Healthcare compare to Nu Skin Enterprises?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PBH vs. The Competition

Prestige Consumer Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Prestige Consumer Healthcare (PBH) Competitors

PBH vs. IPAR, HLF, USNA, NATR, and NUS

How does Prestige Consumer Healthcare compare to Interparfums?

Which has more volatility and risk, IPAR or PBH?

Do insiders & institutionals have more ownership in IPAR or PBH?

Do analysts recommend IPAR or PBH?

Is IPAR or PBH more profitable?

Which has higher valuation & earnings, IPAR or PBH?

Does the media favor IPAR or PBH?

Summary

How does Prestige Consumer Healthcare compare to Herbalife?

Do analysts recommend HLF or PBH?

Which has more volatility & risk, HLF or PBH?

Which has preferable earnings and valuation, HLF or PBH?

Is HLF or PBH more profitable?

Do institutionals and insiders have more ownership in HLF or PBH?

Does the media favor HLF or PBH?

Summary

How does Prestige Consumer Healthcare compare to USANA Health Sciences?

Which has more risk & volatility, PBH or USNA?

Which has better valuation & earnings, PBH or USNA?

Do institutionals & insiders hold more shares of PBH or USNA?

Is PBH or USNA more profitable?

Do analysts rate PBH or USNA?

Does the media refer more to PBH or USNA?

Summary

How does Prestige Consumer Healthcare compare to Nature's Sunshine Products?

Does the media refer more to PBH or NATR?

Do insiders & institutionals hold more shares of PBH or NATR?

Which has more volatility & risk, PBH or NATR?

Do analysts rate PBH or NATR?

Which has higher valuation and earnings, PBH or NATR?

Is PBH or NATR more profitable?

Summary

How does Prestige Consumer Healthcare compare to Nu Skin Enterprises?

Which has preferable earnings & valuation, PBH or NUS?

Which has more volatility and risk, PBH or NUS?

Is PBH or NUS more profitable?

Does the media refer more to PBH or NUS?

Do analysts rate PBH or NUS?

Do insiders and institutionals hold more shares of PBH or NUS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PBH vs. The Competition

Prestige Consumer Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools